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cells that are responsible for neovessel formation. We process fat with centrifugation to concentrate a higher number of viable cells with regenerative potential in a smaller amount of inoculum, which makes this method ideal for the treatment of retracting scar tissue.
In our clinical experience, autologous fat grafting is associated with amelioration both from aesthetic and functional points of view, showing its effectiveness also in improving scar-associated movement impairment. Moving from our experience, we recently published a series of 36 children affected by pathologic dwarfism treated for postsurgical scars resulting from correction of short stature.
Clinical assessment of the study population was conducted using a modified Patient and Observer Scar Assessment Scale, to which a new item was added in the patient section to investigate scar-related movement impairment. This new parameter has been shown to be the feature most closely related to overall patient satisfaction and therefore to patient quality of life. 3 Furthermore, lipostructure is the unique scar therapy able to control the process of scar-associated neuropathic pain.
In our studies on postmastectomy pain syndrome and on Arnold neuralgia, we demonstrated how fat grafting can reduce pain with a clinical reduction of visual analogue scale scores. 4 We postulate that the described analgesic effect is related to nerve liberation and to an induction of molecular changes in the microenvironment of posttraumatic scar, which is hostile to regeneration of the nervous system because of intrinsic inhibitory factors expressed by the extracellular matrix. 4 These conclusions are confirmed by our experience in patients affected by postmastectomy pain syndrome after they have undergone radiotherapy. In this clinical setting, we hypothesize that mesenchymal stem cells could also inhibit production of proinflammatory cytokines, which can induce peripheral and central sensitization with a failed nociception system, leading to pain augmentation. 5 In conclusion, considering its safety, efficacy, and optimal tolerability, we are persuaded that autologous fat grafting is an innovative surgical option for scar tissue treatment. Its regenerative effects are evident not only as an improvement of the skin's complexion, but also as a reduction of pain and as better join mobility. 
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result of scar subcision, but that the grafted adipose tissue played a critical role in improving the scar. Other studies have demonstrated similar outcomes. 3, 4 The use of fat grafting is perhaps most useful in the treatment of stiff and damaged irradiated tissue. In addition to the study by Maione et al. demonstrating improved tissue quality and pain after fat grafting to the irradiated breast, 5 a recent study suggested that autologous fat grafting in conjunction with implant-based breast reconstruction may lower the complication rate in irradiated breasts to a rate comparable to nonirradiated breasts. 6 In animal studies, fat grafting of irradiated tissues has been shown to decrease fibrosis and improve vascularity. In response to this article, we would like to emphasize the importance of the high prevalence of feeding difficulties in children with cleft palate. Ligh et al. demonstrated that feeding difficulties were the most common comorbidity, accounting for 13.4 percent in children with isolated cleft palate. Feeding problems
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